India's Third Largest Drugmaker Cipla Freezes Pay for 300 to 400 Top Managers
MUMBAI: Cipla, India’s third-largest drugmaker by revenue, has decided to trim its ballooning employee cost by freezing increments of 300-400 of its top managers as part of the company’s operational revamp.
In the past five years, Cipla has been a laggard among its peers as management and operational changes dragged the company’s profits down. Cipla’s employee cost has trebled in the past four years, mostly because of several senior
In the past five years, Cipla has been a laggard among its peers as management and operational changes dragged the company’s profits down. Cipla’s employee cost has trebled in the past four years, mostly because of several senior